share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144：拟议出售证券

美股sec公告 ·  02/21 10:20
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer, David Altshuler, is set to sell 3,002 common shares of the company on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Altshuler over the past three months, totaling 7,147 shares for gross proceeds of $3,005,656.38.
Vertex Pharmaceuticals Inc. officer, David Altshuler, is set to sell 3,002 common shares of the company on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Altshuler over the past three months, totaling 7,147 shares for gross proceeds of $3,005,656.38.
Vertex Pharmicals Inc.高管戴维·阿尔特舒勒定于2024年2月21日出售该公司的3,002股普通股，总市值为1,266,153.54美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了Altshuler在过去三个月中的近期销售记录，共计7,147股股票，总收益为3,005,656.38美元。
Vertex Pharmicals Inc.高管戴维·阿尔特舒勒定于2024年2月21日出售该公司的3,002股普通股，总市值为1,266,153.54美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了Altshuler在过去三个月中的近期销售记录，共计7,147股股票，总收益为3,005,656.38美元。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息